Company Details
- Employees
- 218
- Founded
- -
- Address
- 22 Morgan, Irvine,ca 92618,united States
- Industry
- Biotechnology
- Website
- http://www.agendia.com
- HQ
- Irvine, CA
Please complete the CAPTCHA to continue
Agendia, Inc. Provides Review of Successful 2024 Business Wire
Exact's Genomic Health puts rival Agendia in ad watchdog's crosshairs over LinkedIn posts Fierce Pharma
National Advertising Division Recommends Agendia Disclose Material Connection to Doctor Featured in Social Media Posts Yahoo Finance
Genomic Testing: When Knowledge Gives You the Strength to Keep Fighting FinancialContent
I Took Control Of My Health By Learning To Speak Up At The Doctor’s Office GirlTalkHQ
Agendia to Present FLEX Study Data on Impact of BluePrint® at ESMO Breast Cancer 2025 Business Wire
Agendia Charles Tangu Obituary (2025) - Houston, TX - Unity Funeral Home Legacy obituary
MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients Wiley Online Library
Agendia® Names Joyce A. O'Shaughnessy, MD as New Principal Investigator for FLEX Study PR Newswire
Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care Illumina
NCCN Adds MammaPrint Gene Expression Assay to Breast Cancer Guidelines OncLive
A Personalized Genetic Test for Breast Cancer Arrives in Europe Labiotech.eu
ASCO: Agendia test spots ultralow breast cancer recurrence risks, flagging women who could skip chemo Fierce Biotech
Agendia Unveils New Real-World-Evidence from FLEX, Highlighting the Expanding Utility of MammaPrint® and BluePrint® for Predicting Neoadjuvant Chemosensitivity and Potential Resistance to CDK4/6 Inhibition in Early-Stage Breast Cancer at SABCS 20 Business Wire
New Neoadjuvant Trial Confirms the Predictive Utility of MammaPrint® + BluePrint® PR Newswire
Agendia Demonstrates MammaPrint® Utility in Predicting Chemotherapy Benefit Over 5 Years in Patients with HR+HER2- Early Breast Cancer at SABCS 2024 BioSpace
Agendia's FLEX Study Reaches Enrollment of Over 17,000 Early-Stage Breast Cancer Patients Across Diverse Population BioSpace
MammaPrint® Reimbursement Indication Extended in Belgium Business Wire
Agendia Again Loses Bid for Breast Cancer Test Medicare Payment Bloomberg Law News
in Prediction of Extended Endocrine Therapy in Journal of Clinical Oncology Business Wire
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint® BluePrint® Breast Cancer Kit to Market PR Newswire
Illumina deal takes Agendia’s tests directly to hospitals BioCentury
AGDX IPO News - Breast cancer diagnostics provider Agendia withdraws $75 million IPO renaissancecapital.com
Agendia, Inc to pay $8.25 million for Medicare false claims; Mercy Health – Lourdes Hospital also settles KFVS12
Agendia Eyes Commercial Expansion, Collaborations with $35M Financing Inside Precision Medicine
Agendia Teams With Ilumina To Transform Breast Cancer Testing Through NGS Advancement The Healthcare Technology Report.
Why She's Using A Breast Cancer Flash Mob to Create Awareness: Cari Grundman HuffPost
What's Going Around: flu and pneumonia KPLC 7 News
Breast cancer tests spawn marketing war Orange County Register
How innovative genomic testing is transforming early breast cancer care | User | poteaudailynews.com FinancialContent
1 +180168XXXXX
3 +130332XXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.